FDA approval for Pfizer, Acura pain drug
OXECTA, an immediate-release oxycodone HCl medicine, is indicated for the management of acute and chronic moderate to severe pain where the use of an opioid analgesic is appropriate.
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
ALD518 is an investigational monoclonal antibody to the pro-inflammatory cytokine IL-6 that is being developed by Bristol-Myers Squibb for autoimmune indications. The Phase 2b randomized, double-blind, placebo controlled
The partnership also involves TransPerfect’s Trial Interactive Portal Technology, which is already being used by biopharmaceutical firms for electronic Trial Master Files, investigator portals, IRB and central laboratory